Ledger.Open graph →
SEC Form D · filed September 8, 2020

Nido Biosciences, Inc

Offering
$46.0M
Sold
$18.4M
Exemption
Rule 506(b)
Industry
Other
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Jamil Beg · Cambridge, MAExec · DirectorAndrew Hedin · Cambridge, MADirectorJacqueline Grant · Cambridge, MADirectorAndrew Hedin · Cambridge, MADirectorJamil Beg · Boston, MAExec · DirectorJacqueline Grant · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗